Home News Join Kanda at BIO-IT World Conference & Expo SEPT 20-22, 2021

Join Kanda at BIO-IT World Conference & Expo SEPT 20-22, 2021

Join the Kanda Team at the Bio-IT World Conference from September 20th-22nd and visit us at booth #207 to learn about our Lab to FDA Approval Workflow Automation services, Data and MetaData Management, Integrated Real World Data solutions and Advanced Analytics with ML/AI, DaaS and Data Virtualization Platforms and Compliant Cloud Application Development.

Schedule a meeting during the event by contacting STARTEAECSTRINGYzJlOTc3OTYxYTk0OWI0YjlmOTU3MzJiNWYxNDJkNzVjb250YWN0QGthbmRhc29mdC5jb21jMmU5Nzc5NjFhOTQ5YjRiOWY5NTczMmI1ZjE0MmQ3NQ==ENDEAECSTRING.

On Wednesday, September 22nd at 11:40 am – our very own Life Sciences Manager and Bioinformatics subject matter expert Yev Monisova will be hosting a discussion about ML / AI analytics infrastructure and Real World Evidence (RWE) insights and visualizations.
Transforming real world data into real world avidence with ai

For two decades now, people across all subdivisions of the healthcare and life sciences industries have gathered to share novel ideas, unique perspectives and bold opportunities at the Bio-IT World Conference, and this year is no exception! The 20th anniversary of this prolific event will take place in our very own city of Boston from September 20th – 22nd as a hybrid event with an emphasis on the future of biomedical research, R&D, drug discovery, and all of the latest innovations in Life Sciences and Precision Medicine.

With over 150 unique presentations and 8 interactive workshops spread out across the span of 3 days, this year’s conference is shaping up to be one of the largest in its 20 year history. Bio-IT World connects a diverse community of healthcare, life sciences, technology, software, informatics, clinical and pharmaceutical experts from over 30 countries around the world in a setting that is designed to facilitate dialogue and discourse.

To find out more about the event visit the Bio-IT World website.

Back to All News